Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
Molecular Cancer Therapeutics
|
August 1, 2012
REST is a novel prognostic factor and therapeutic target for medulloblastoma
Pete Taylor, Jason Fangusaro, Veena Rajaram, et al.
Oncotarget
|
February 14, 2018
REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature
Shavali Shaik, Bridget Kennis, Shinji Maegawa, et al.
Neuro-Oncology
|
April 19, 2019
Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients
Jeffrey P Gross, Stephanie Powell, Frank Zelko, et al.
Neuro-Oncology
|
February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials
Adriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial
Jason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
Neuro-Oncology
|
November 9, 2023
Pediatric low-grade glioma: State-of-the-art and ongoing challenges
Jason Fangusaro, David T Jones, Roger J Packer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2019
Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study
Jason Fangusaro, Shengjie Wu, Shannon MacDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018
Katherine E Warren, Stewart Goldman, Ian F Pollack, et al.
Neuro-Oncology
|
August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
Regina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Neuro-Oncology
|
September 29, 2012
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
Molecular Cancer Therapeutics
|
August 1, 2012
REST is a novel prognostic factor and therapeutic target for medulloblastoma
Pete Taylor, Jason Fangusaro, Veena Rajaram, et al.
Oncotarget
|
February 14, 2018
REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature
Shavali Shaik, Bridget Kennis, Shinji Maegawa, et al.
Neuro-Oncology
|
April 19, 2019
Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients
Jeffrey P Gross, Stephanie Powell, Frank Zelko, et al.
Neuro-Oncology
|
February 26, 2022
Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials
Adriana Fonseca, Cecile Faure-Conter, Matthew J Murray, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial
Jason Fangusaro, Duane A Mitchell, Mehmet Kocak, et al.
Neuro-Oncology
|
November 9, 2023
Pediatric low-grade glioma: State-of-the-art and ongoing challenges
Jason Fangusaro, David T Jones, Roger J Packer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2019
Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study
Jason Fangusaro, Shengjie Wu, Shannon MacDonald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 15, 2010
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018
Katherine E Warren, Stewart Goldman, Ian F Pollack, et al.
Neuro-Oncology
|
August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas
Regina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Neuro-Oncology
|
September 29, 2012
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study
Sridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Page
of 8